ORIC PHARMACEUTICALS INC (ORIC)
US68622P1093 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -101.76M | -100.70M | -89.12M | -78.72M | -73.70M | |||
| Depreciation Amortization | 1.04M | 1.03M | 970.00K | 900.00K | 970.00K | |||
| Change In Working Capital | -3.58M | 4.90M | -450.00K | 4.07M | 2.05M | |||
| Other non cash items | 9.06M | 9.08M | 13.46M | 14.20M | 25.42M | |||
| OPERATING CASH FLOW | -95.24M | -85.69M | -75.14M | -59.54M | -45.27M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -757.00K | -849.00K | -2.08M | -940.00K | -670.00K | |||
| Other Investing Activity | -117.29M | -42.55M | -107.17M | 159.37M | -215.29M | |||
| INVESTING CASH FLOW | -118.05M | -43.40M | -109.25M | 158.44M | -215.96M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 211.08M | 85.89M | 25.62M | 50.99M | 271.75M | |||
| Other Financing Activity | N/A | -227.00K | -400.00K | -1.85M | -21.24M | |||
| FINANCING CASH FLOW | 210.69M | 85.66M | 25.23M | 49.13M | 250.51M | |||
| CHANGE IN CASH | -2.61M | -43.43M | -159.16M | 148.03M | -10.72M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -95.24M | -85.69M | -75.14M | -59.54M | -45.27M | |||
| Capital Expenditure | -757.00K | -849.00K | -2.08M | -940.00K | -670.00K | |||
| FREE CASH FLOW | -96.00M | -86.54M | -77.22M | -60.48M | -45.94M | |||
All data in USD